GL1X · GenesisL1 explorer

MolNFT v1 · #8764 · protein

Crosslinked haemoglobin

1HAB · Hemoglobin a: “Crosslinked haemoglobin”. X-ray diffraction, 3 ligands (HEM, CIN, CMO), 7 pockets (best druggability 0.85). MolNFT v1 #8764 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1HAB
Type
protein
Length
574 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemoglobin a
UniProt
P69905, P68871
Ligands
HEM, CIN, CMO
Pockets
7 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 80% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CHemoglobin aprotein14179% helix, 0% strandP69905
B, DHemoglobin aprotein14682% helix, 0% strandP68871

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 4 copies · chains A, B, C, D
  • CIN · 4-carboxycinnamic acid · ligand · chains B, D
  • CMO · Carbon monoxide · ion · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19690.850.8697empty
22580.730.8628HEM, CMO
32640.720.8628HEM, CMO
42110.710.8624HEM, CMO
52000.690.8524HEM, CMO

Interfaces

6 interfaces between chains.

  • A–B · 907 Ų buried · 17 hydrogen bonds · protein-protein
  • C–D · 889 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 502 Ų buried · 3 hydrogen bonds · protein-protein
  • A–D · 471 Ų buried · 2 hydrogen bonds · protein-protein
  • A–C · 299 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1HAB · Crosslinked haemoglobin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.